JUN is the most widely used protein in activating protein 1 complex, (Bin et al. (2020) discovered that c-Jun is a potential novel therapeutic target for COPD, JNK inhibition by erythromycin restores corticosteroid sensitivity via the inhibition of c-Jun expression. This evidence concerns the gene JUN and chronic obstructive pulmonary disease.